Funded Tech Companies
XyloCor Therapeutics
XyloCor Therapeutics, based in Newtown Square, received equity investments through Longwood Fund, Life Sciences Partners and Fountain Healthcare Partners.
Company Overview
Company Name
XyloCor Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
76 Longview Ln.
Newtown Square, PA 19073
USA
Newtown Square, PA 19073
USA
Phone
Website
Email Address
Company Background Information
Overview
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our lead product candidate, XC001, is in clinical development for patients with refractory angina for which there are no treatment options.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/24/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Albert Gianchetti
Chief Medical Officer
Rickey Reinhardt
VP - Finance
Michael Carson
VP - Manufacturing
Alexander Gaidamaka
VP - Operations
Dawn Byrnes
VP - R & D
Howard Dittrich
Company Investors
- Longwood Fund
- Life Sciences Partners
- Fountain Healthcare Partners (Aidan King)
- Sofinnova Ventures (Perry Nisen)
- Lumira Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs